Aurora Cannabis Inc. and MedReleaf Corp. announced the closing of the previously announced arrangement agreement. Under the terms of the Arrangement Agreement, holders of MedReleaf common shares received 3.575 common shares of Aurora for each MedReleaf common share held. Following closing of the Arrangement Agreement Norma Beauchamp and Ronald Funk have been appointed to Aurora's Board of Directors. Allan Cleiren, Aurora's Chief Operating Officer, will assume the role of interim-CEO of MedReleaf.